BioNexus Gene Lab
BGLC
#11183
Rank
NZ$4.36 M
Marketcap
NZ$1.49
Share price
-9.43%
Change (1 day)
-81.93%
Change (1 year)

EPS for BioNexus Gene Lab (BGLC)

EPS in 2026 (TTM): NZ-$1.84

According to BioNexus Gene Lab's latest financial reports the company's current EPS (TTM) is NZ-$1.96. In 2025 the company made an earnings per share (EPS) of NZ-$2.91 a decrease over its 2024 EPS that were of NZ-$1.63.

EPS history for BioNexus Gene Lab from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.84-36.74%
2025NZ-$2.9179.15%
2024NZ-$1.63-45.96%
2023NZ-$3.01260.87%
2022NZ-$0.83-195.83%
2021NZ$0.87-66.67%
2020NZ$2.61-600.17%
2019NZ-$0.52-1031.69%
2018NZ$0.05603

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ-$2.45 24.88%๐Ÿ‡บ๐Ÿ‡ธ USA